Disclaimer

Helios Towers plc is covered by research analysts at eight registered investment research firms: BofA Securities, Barclays, Berenberg, Citi Research, Deutsche Numis, Jefferies, Morgan Stanley and Quest (Canaccord Genuity).

These forecasts are not endorsed by Helios Towers plc, nor does Helios Towers plc assume any obligation to update or revise the consensus to reflect circumstances arising after the date below.

This consensus has been compiled by Helios Towers plc as of 11 August 2025. The consensus reflects financial forecasts from all registered investment analysts who have released research including updated financial forecasts within the seven months prior to the compilation date. Firms contributing to the full-year consensus were: BofA Securities, Barclays, Berenberg, Citi Research, Deutsche Numis and Jefferies.

Analyst consensus

(In US$m, unless indicated otherwise)FY2025FY2026FY2027
MeanHighLowMeanHighLowMeanHighLow
Sites (#)14,70714,78514,65215,03315,12814,91115,29015,42714,966
Tenancies (#)31,62531,70631,50633,46733,83132,60634,85035,78133,106
EBITDA(1)466.7469.8462.3517.9528.0503.7567.1590.3542.0
RFCF(2)167.4182.9152.2213.2245.2193.0251.3298.5216.3
FCF(3)51.659.737.9106.5126.279.7156.8182.3115.1
Capex162.4170.1156.2155.5164.3136.6145.1169.8117.0

Analyst coverage

InstitutionNamePhoneLast updateRecommendationPrice target
BofA SecuritiesDavid Wrightn.a.13/03/2025Buy165
BerenbergAlex Shortn.a.13/03/2025Buy175
Citi ResearchRohit Modin.a.25/07/2025Buy145
Deutsche NumisJohn Karidis+44 20 7260 131114/04/2025Buy255
JefferiesGraham Huntn.a.10/07/2025Buy186
Morgan StanleyEmmet Kelly+44 20 7425 683010/03/2025Overweight160
New StreetChris Hoaren.a.26/09/2024Buy140
Quest (Canaccord Genuity)James Congden+44 20 7523 843723/05/2022Buy305

(1) Adjusted EBITDA is defined as loss for the period, adjusted for tax expenses, finance costs, gain/(loss) on derivative financial instruments, interest receivable, loss on disposal of property, plant and equipment, amortisation of intangible assets, depreciation and impairment of property, plant and equipment, depreciation of right-of-use assets, recharged depreciation, deal costs, share-based payments and long-term incentive plan charges, and exceptional items. Exceptional items are material items that are considered exceptional in nature by management by virtue of their size and/or incidence.

(2) Portfolio free cash flow is defined as Adjusted EBITDA less maintenance and corporate capital additions, payments of lease liabilities (including interest and principal repayments of lease liabilities) and tax paid.